BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38730662)

  • 1. Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
    Denu RA; Joseph CP; Urquiola ES; Byrd PS; Yang RK; Ratan R; Zarzour MA; Conley AP; Araujo DM; Ravi V; Nassif Haddad EF; Nakazawa MS; Patel S; Wang WL; Lazar AJ; Somaiah N
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730662
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
    Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
    Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
    Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
    Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
    Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
    JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
    Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
    BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 9. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
    Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
    BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
    Celestino R; Lima J; Faustino A; Vinagre J; Máximo V; Gouveia A; Soares P; Lopes JM
    Eur J Hum Genet; 2013 May; 21(5):503-10. PubMed ID: 22948025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
    Bombac A; Zakotnik B; Bucic M; Setrajcic Dragos V; Gazic B; Stegel V; Klancar G; Novakovic S
    Int J Oncol; 2020 Jun; 56(6):1468-1478. PubMed ID: 32236636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.
    Brenca M; Rossi S; Polano M; Gasparotto D; Zanatta L; Racanelli D; Valori L; Lamon S; Dei Tos AP; Maestro R
    J Pathol; 2016 Mar; 238(4):543-9. PubMed ID: 26606880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
    Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
    Shi E; Chmielecki J; Tang CM; Wang K; Heinrich MC; Kang G; Corless CL; Hong D; Fero KE; Murphy JD; Fanta PT; Ali SM; De Siena M; Burgoyne AM; Movva S; Madlensky L; Heestand GM; Trent JC; Kurzrock R; Morosini D; Ross JS; Harismendy O; Sicklick JK
    J Transl Med; 2016 Dec; 14(1):339. PubMed ID: 27974047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors.
    Wagner AJ; Remillard SP; Zhang YX; Doyle LA; George S; Hornick JL
    Mod Pathol; 2013 Feb; 26(2):289-94. PubMed ID: 22955521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).
    Nannini M; Astolfi A; Urbini M; Indio V; Santini D; Heinrich MC; Corless CL; Ceccarelli C; Saponara M; Mandrioli A; Lolli C; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Cancer; 2014 Sep; 14():685. PubMed ID: 25239601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
    Kalfusová A; Kodet R
    Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST.
    Astolfi A; Indio V; Nannini M; Saponara M; Schipani A; De Leo A; Altimari A; Vincenzi B; Comandini D; Grignani G; Secchiero P; Urbini M; Pantaleo MA
    Front Oncol; 2020; 10():504. PubMed ID: 32391261
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.
    Agaram NP; Wong GC; Guo T; Maki RG; Singer S; Dematteo RP; Besmer P; Antonescu CR
    Genes Chromosomes Cancer; 2008 Oct; 47(10):853-9. PubMed ID: 18615679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Schipani A; Nannini M; Astolfi A; Pantaleo MA
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.